Cytosorbents (CTSO) Misses Q4 EPS by 3c

Cytosorbents (NASDAQ: CTSO) reported Q4 EPS of ($0.07), $0.03 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $9.2 million versus the consensus estimate of $10.57 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.

You May Also Be Interested In

• UGI shares spike on reported KKR bid for the company
• Sypris Solutions (SYPR) Reports Q2 Loss of $0.14
• Suncrete Inc (RMIX) PT Lowered to $22 at Jefferies